Cargando…

The role of Spectral Domain Optical Coherence Tomography in monitoring uncontrolled hypertensive type 2 diabetic patients

Rationale: The pathogenesis of diabetic retinopathy is multifactorial, and a range of hyperglycemia-linked pathways has been implicated in the initiation and progression of this condition. All the cells in the retina are affected by the diabetic milieu, and in view of such disease and tissue complex...

Descripción completa

Detalles Bibliográficos
Autores principales: Stana, D, Iancu, R, Leasu, C, Popescu, V, Dumitrescu, A, Gradinaru, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Carol Davila University Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4813620/
https://www.ncbi.nlm.nih.gov/pubmed/27057251
_version_ 1782424305951309824
author Stana, D
Iancu, R
Leasu, C
Popescu, V
Dumitrescu, A
Gradinaru, S
author_facet Stana, D
Iancu, R
Leasu, C
Popescu, V
Dumitrescu, A
Gradinaru, S
author_sort Stana, D
collection PubMed
description Rationale: The pathogenesis of diabetic retinopathy is multifactorial, and a range of hyperglycemia-linked pathways has been implicated in the initiation and progression of this condition. All the cells in the retina are affected by the diabetic milieu, and in view of such disease and tissue complexity, it is unlikely that any single process is solely responsible for the retinal pathophysiology. Dyslipidemia is considered a trigger to rapid worsening of the condition and its treatment is becoming a part of normal diabetes treatment. Nevertheless, as establishing causal mechanisms and related conditions remain an important research goal, also the means to follow up the impact on the retina and other ocular tissues are as important. Objective: this retrospective study shows the progression of diabetic macular edema (DME) in patients with dyslipidemia related to poor glycemic and blood control in subjects with existing DME by measuring the total macular volume (TMV) and thickness through the spectral domain optical coherence tomography (SD- OCT). Methods and results: 30 uncontrolled cases of type 2 diabetes that were measured monthly by SD- OCT through a period of 3 months with correlation to the degree of dyslipidemia and hyperglycemia, were analyzed. Conclusion: The role of OCT in monitoring the progression of DME in patients with uncontrolled type 2 diabetes is essential and the collaboration between the ophthalmologist and endocrinologist is essential to monitor the course of disease in uncontrolled patients.
format Online
Article
Text
id pubmed-4813620
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Carol Davila University Press
record_format MEDLINE/PubMed
spelling pubmed-48136202016-04-07 The role of Spectral Domain Optical Coherence Tomography in monitoring uncontrolled hypertensive type 2 diabetic patients Stana, D Iancu, R Leasu, C Popescu, V Dumitrescu, A Gradinaru, S J Med Life Case Presentations Rationale: The pathogenesis of diabetic retinopathy is multifactorial, and a range of hyperglycemia-linked pathways has been implicated in the initiation and progression of this condition. All the cells in the retina are affected by the diabetic milieu, and in view of such disease and tissue complexity, it is unlikely that any single process is solely responsible for the retinal pathophysiology. Dyslipidemia is considered a trigger to rapid worsening of the condition and its treatment is becoming a part of normal diabetes treatment. Nevertheless, as establishing causal mechanisms and related conditions remain an important research goal, also the means to follow up the impact on the retina and other ocular tissues are as important. Objective: this retrospective study shows the progression of diabetic macular edema (DME) in patients with dyslipidemia related to poor glycemic and blood control in subjects with existing DME by measuring the total macular volume (TMV) and thickness through the spectral domain optical coherence tomography (SD- OCT). Methods and results: 30 uncontrolled cases of type 2 diabetes that were measured monthly by SD- OCT through a period of 3 months with correlation to the degree of dyslipidemia and hyperglycemia, were analyzed. Conclusion: The role of OCT in monitoring the progression of DME in patients with uncontrolled type 2 diabetes is essential and the collaboration between the ophthalmologist and endocrinologist is essential to monitor the course of disease in uncontrolled patients. Carol Davila University Press 2014 /pmc/articles/PMC4813620/ /pubmed/27057251 Text en ©Carol Davila University Press http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Presentations
Stana, D
Iancu, R
Leasu, C
Popescu, V
Dumitrescu, A
Gradinaru, S
The role of Spectral Domain Optical Coherence Tomography in monitoring uncontrolled hypertensive type 2 diabetic patients
title The role of Spectral Domain Optical Coherence Tomography in monitoring uncontrolled hypertensive type 2 diabetic patients
title_full The role of Spectral Domain Optical Coherence Tomography in monitoring uncontrolled hypertensive type 2 diabetic patients
title_fullStr The role of Spectral Domain Optical Coherence Tomography in monitoring uncontrolled hypertensive type 2 diabetic patients
title_full_unstemmed The role of Spectral Domain Optical Coherence Tomography in monitoring uncontrolled hypertensive type 2 diabetic patients
title_short The role of Spectral Domain Optical Coherence Tomography in monitoring uncontrolled hypertensive type 2 diabetic patients
title_sort role of spectral domain optical coherence tomography in monitoring uncontrolled hypertensive type 2 diabetic patients
topic Case Presentations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4813620/
https://www.ncbi.nlm.nih.gov/pubmed/27057251
work_keys_str_mv AT stanad theroleofspectraldomainopticalcoherencetomographyinmonitoringuncontrolledhypertensivetype2diabeticpatients
AT iancur theroleofspectraldomainopticalcoherencetomographyinmonitoringuncontrolledhypertensivetype2diabeticpatients
AT leasuc theroleofspectraldomainopticalcoherencetomographyinmonitoringuncontrolledhypertensivetype2diabeticpatients
AT popescuv theroleofspectraldomainopticalcoherencetomographyinmonitoringuncontrolledhypertensivetype2diabeticpatients
AT dumitrescua theroleofspectraldomainopticalcoherencetomographyinmonitoringuncontrolledhypertensivetype2diabeticpatients
AT gradinarus theroleofspectraldomainopticalcoherencetomographyinmonitoringuncontrolledhypertensivetype2diabeticpatients
AT stanad roleofspectraldomainopticalcoherencetomographyinmonitoringuncontrolledhypertensivetype2diabeticpatients
AT iancur roleofspectraldomainopticalcoherencetomographyinmonitoringuncontrolledhypertensivetype2diabeticpatients
AT leasuc roleofspectraldomainopticalcoherencetomographyinmonitoringuncontrolledhypertensivetype2diabeticpatients
AT popescuv roleofspectraldomainopticalcoherencetomographyinmonitoringuncontrolledhypertensivetype2diabeticpatients
AT dumitrescua roleofspectraldomainopticalcoherencetomographyinmonitoringuncontrolledhypertensivetype2diabeticpatients
AT gradinarus roleofspectraldomainopticalcoherencetomographyinmonitoringuncontrolledhypertensivetype2diabeticpatients